Interpreted Prediction
Predicted the patent for Semaglutide will expire in FY26.
AI Evaluation Notes
Multiple sources confirm that key patents for Semaglutide, particularly for Ozempic, are indeed set to expire in January 2026, which falls within Fiscal Year 2026. While other patents may extend longer, the prediction of a patent expiry in FY26 is accurate.